Hybrigenics Posts 17 Percent Jump in Revenues from Protein Interaction Business
February 03, 2012
Hybrigenics Posts 17 Percent Jump in Revenues from Protein Interaction Business
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Hybrigenics Signs Three-Year, $2.4M Renewal of Protein Interaction Services Deal
September 28, 2012 / ProteoMonitor - GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
May 18, 2012 / ProteoMonitor - Scripps Study Highlights Protein Sulfenylation as Regulator of EGFR Activity, Potential Drug Target
December 16, 2011 / ProteoMonitor - Cellzome Snags More Than $3.1M in Grants for EU-, UK-Sponsored Research Initiatives
December 9, 2011 / ProteoMonitor - Hybrigenics' H1 Revenue Down 2 Percent, But Proteomics Services Up 8 Percent
October 21, 2011 / ProteoMonitor